Utilisation of primary care electronic patient records for identification and targeted invitation of individuals to a lung cancer screening programme
Copyright © 2022 The Author(s). Published by Elsevier B.V. All rights reserved..
Lung cancer screening (LCS) eligibility is largely determined by tobacco consumption. Primary care smoking data could guide LCS invitation and eligibility assessment. We present observational data from the SUMMIT Study, where individual self-reported smoking status was concordant with primary care records in 75.3%. However, 10.3% demonstrated inconsistencies between historic and most recent smoking status documentation. Quantified tobacco consumption was frequently missing, precluding direct LCS eligibility assessment. Primary care recorded "ever-smoker" status, encompassing both recent and historic documentation, can be used to target LCS invitation. Identifying those with missing or erroneous "never-smoker" smoking status is crucial for equitable invitation to LCS.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:173 |
|---|---|
| Enthalten in: |
Lung cancer (Amsterdam, Netherlands) - 173(2022) vom: 19. Nov., Seite 94-100 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Dickson, Jennifer L [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Journal Article |
|---|
| Anmerkungen: |
Date Completed 20.10.2022 Date Revised 20.03.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.lungcan.2022.09.009 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM346950554 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM346950554 | ||
| 003 | DE-627 | ||
| 005 | 20240320232836.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.lungcan.2022.09.009 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1337.xml |
| 035 | |a (DE-627)NLM346950554 | ||
| 035 | |a (NLM)36179541 | ||
| 035 | |a (PII)S0169-5002(22)00635-3 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Dickson, Jennifer L |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Utilisation of primary care electronic patient records for identification and targeted invitation of individuals to a lung cancer screening programme |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 20.10.2022 | ||
| 500 | |a Date Revised 20.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2022 The Author(s). Published by Elsevier B.V. All rights reserved. | ||
| 520 | |a Lung cancer screening (LCS) eligibility is largely determined by tobacco consumption. Primary care smoking data could guide LCS invitation and eligibility assessment. We present observational data from the SUMMIT Study, where individual self-reported smoking status was concordant with primary care records in 75.3%. However, 10.3% demonstrated inconsistencies between historic and most recent smoking status documentation. Quantified tobacco consumption was frequently missing, precluding direct LCS eligibility assessment. Primary care recorded "ever-smoker" status, encompassing both recent and historic documentation, can be used to target LCS invitation. Identifying those with missing or erroneous "never-smoker" smoking status is crucial for equitable invitation to LCS | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Lung cancer | |
| 650 | 4 | |a Lung cancer screening | |
| 700 | 1 | |a Hall, Helen |e verfasserin |4 aut | |
| 700 | 1 | |a Horst, Carolyn |e verfasserin |4 aut | |
| 700 | 1 | |a Tisi, Sophie |e verfasserin |4 aut | |
| 700 | 1 | |a Verghese, Priyam |e verfasserin |4 aut | |
| 700 | 1 | |a Worboys, Sarah |e verfasserin |4 aut | |
| 700 | 1 | |a Perugia, Andrew |e verfasserin |4 aut | |
| 700 | 1 | |a Rusius, James |e verfasserin |4 aut | |
| 700 | 1 | |a Mullin, Anne-Marie |e verfasserin |4 aut | |
| 700 | 1 | |a Teague, Jonathan |e verfasserin |4 aut | |
| 700 | 1 | |a Farrelly, Laura |e verfasserin |4 aut | |
| 700 | 1 | |a Bowyer, Vicky |e verfasserin |4 aut | |
| 700 | 1 | |a Gyertson, Kylie |e verfasserin |4 aut | |
| 700 | 1 | |a Bojang, Fanta |e verfasserin |4 aut | |
| 700 | 1 | |a Levermore, Claire |e verfasserin |4 aut | |
| 700 | 1 | |a Anastasiadis, Tania |e verfasserin |4 aut | |
| 700 | 1 | |a McCabe, John |e verfasserin |4 aut | |
| 700 | 1 | |a Devaraj, Anand |e verfasserin |4 aut | |
| 700 | 1 | |a Nair, Arjun |e verfasserin |4 aut | |
| 700 | 1 | |a Navani, Neal |e verfasserin |4 aut | |
| 700 | 1 | |a Hackshaw, Allan |e verfasserin |4 aut | |
| 700 | 1 | |a Quaife, Samantha L |e verfasserin |4 aut | |
| 700 | 1 | |a Janes, Sam M |e verfasserin |4 aut | |
| 700 | 0 | |a SUMMIT consortium |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Lung cancer (Amsterdam, Netherlands) |d 1994 |g 173(2022) vom: 19. Nov., Seite 94-100 |w (DE-627)NLM074973657 |x 1872-8332 |7 nnns |
| 773 | 1 | 8 | |g volume:173 |g year:2022 |g day:19 |g month:11 |g pages:94-100 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.lungcan.2022.09.009 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 173 |j 2022 |b 19 |c 11 |h 94-100 | ||